Uncovering Social Disparities in Early-Onset Colorectal Cancer
- Abdominal Cancers Alliance
- Jun 30
- 2 min read
Oral Abstract #11005, 2025 ASCO Annual Meeting
By Lisa Herms, Saamir Pasha, Jinhong Guo, Paul Conkling, Jess Paulus
Background
Researchers analyzed health records from almost 15,000 patients under 50 with colorectal cancer to shed light on the social determinants of health and other factors causing a significant rise in early-onset colorectal cancer in patients. While there has been a decrease in colorectal cancer rates among older adults, there has been a significant rise in patients diagnosed before age 50.

Key Findings
Disproportionate impact on certain groups
Younger patients from Black, Asian, Hispanic, American Indian, and Alaska Native backgrounds were more commonly seen in the under-50 group than in the average-onset group
More common advanced cancer at diagnosis
Under-50 patients were more likely to be diagnosed at a late stage (Stage III or IV), which significantly worsens survival chances
Slightly more obesity and smoking among younger patients
Those under 50 were more likely to be obese or smokers compared to older colorectal cancer patients
Stage at diagnosis is critical
Regardless of age, how advanced the cancer is when first found is the strongest predictor of survival, so finding it early is key
What This Means
Current screening starts too late: Even after U.S. guidelines lowered the recommended age to 45, half of the early-onset cases occurred in people younger than that, meaning they’d still be missed
Better targeting may help: Instead of screening everyone younger than 45, researchers suggest identifying high-risk individuals—for example, those with obesity or certain racial/ethnic backgrounds—and screening them earlier
Conclusion
Bottom Line: Early detection saves lives. Colorectal cancer is increasingly affecting adults under 50, especially from certain racial backgrounds and those with obesity. These cases are often diagnosed too late, which drastically lowers survival chances. To address this, experts recommend smarter screening strategies focused on high-risk younger adults and quicker diagnostic steps when symptoms appear.
Read the full article here.
If you have questions about your treatment options, speak with your doctor to determine the best plan for you.